Research
Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis
BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i1777 (Published 21 April 2016) Cite this as: BMJ 2016;353:i1777
Data supplement
Data supplement
Files in this Data Supplement:
- Web appendix 1 - Statistical code
- Web appendix 2 - Details of included studies
- Web appendix 3 - Additional results
- Web appendix 4 - GRADE Quality Appraisal
- Web appendix 5 - Sensitivity analyses for modeling assumptions
Related articles
- Research Methods & Reporting Published: 18 October 2011; BMJ 343 doi:10.1136/bmj.d5928
- Research Methods & Reporting Published: 24 September 2014; BMJ 349 doi:10.1136/bmj.g5630
- Research Published: 07 July 2020; BMJ 370 doi:10.1136/bmj.m2288
- Research Methods & Reporting Published: 10 November 2020; BMJ 371 doi:10.1136/bmj.m3907
- Research Methods & Reporting Published: 11 November 2020; BMJ 371 doi:10.1136/bmj.m3900
See more
- NICE recommends new CAR-T treatment for lymphoma for some patients on NHSBMJ January 20, 2021, 372 n184; DOI: https://doi.org/10.1136/bmj.n184
- NHS should vary price it pays for cancer drugs to improve access, say expertsBMJ November 09, 2020, 371 m4322; DOI: https://doi.org/10.1136/bmj.m4322
- Colon cancer screening should begin at 45, says US task forceBMJ October 29, 2020, 371 m4188; DOI: https://doi.org/10.1136/bmj.m4188
- Leading oncologist faces GMC allegations of inappropriate treatment of dying patientsBMJ September 15, 2020, 370 m3594; DOI: https://doi.org/10.1136/bmj.m3594
- Covid-19: Waiting times in England reach record highsBMJ September 11, 2020, 370 m3557; DOI: https://doi.org/10.1136/bmj.m3557
Cited by...
- GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework
- GRADE approach to drawing conclusions from a network meta-analysis using a partially contextualised framework
- Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data
- Planning a future randomized clinical trial based on a network of relevant past trials
- A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality
- Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review
- Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2)
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
- Denosumab, cortical bone and bone erosions in rheumatoid arthritis